Login / Signup

Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations.

Kevin J FrostAshley Ryan HamiltonStephen HughesConor JamiesonPaul RaffertyOliver TroiseAbi Jenkins
Published in: European journal of hospital pharmacy : science and practice (2022)
PROSPERO (CRD42021250022).
Keyphrases
  • gram negative
  • systematic review
  • high dose
  • multidrug resistant
  • meta analyses
  • low dose
  • stem cell transplantation
  • clinical practice